MENU

Articles for Hikma Pharmaceuticals (LSE: HIK)

2 cheap growth stocks I’d buy for the long term

These two shares could offer a mix of growth and value in current market conditions. More »

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential. More »

Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys. More »

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright. More »

2 turnaround stocks I’d consider buying before 2018

Could these two turnaround stocks beat the market in 2018 and beyond? More »

Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results. More »

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player. More »

2 growth stocks for the long run

These two stocks could perform well in future years. More »

2 turnaround stocks that could make you rich

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays. More »

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). More »

Why this battered pharma stock could be a top turnaround buy

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers. More »

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend? More »

These 2 battered stocks look set for a return to growth

These two hot recovery prospects certainly carry some risk, but they could provide great rewards for brave investors. More »

2 FTSE 350 growth stocks I’d buy ASAP

Now could be the perfect time to pick up shares in these two FTSE 350 (INDEXFTSE:NMX) growth companies. More »

Are these bombed-out pharma stocks worth buying?

Should you catch these falling knives? More »

2 ‘hot’ growth stocks I’d buy before it’s too late

Bilaal Mohamed explains why investors should consider these growth stocks before it's too late. More »

Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade

Hikma Pharmaceuticals plc (LON: HIK) could be a stunning long-term growth stock. More »

2 FTSE 100 growth stocks to buy before it’s too late?

Royston Wild discusses the investment potential of two FTSE 100 (INDEXFTSE: UKX) growth shares. More »

These FTSE 100 stocks rocketed 20% in February. Can they keep going?

Royston Wild runs the rule over two FTSE 100 (INDEXFTSE: UKX) chargers. More »

Why this growth stock could soar 40%+ within 2 years

Stunning gains could be on the horizon for this company. More »